Published in Am Rev Respir Dis on October 01, 1988
The influence of obstructive sleep apnea and gender on genioglossus activity during rapid eye movement sleep. Chest (2008) 1.21
The respiratory response to inspiratory resistive loading during rapid eye movement sleep in humans. J Physiol (2000) 1.09
Nocturnal saturation and respiratory muscle function in patients with chronic obstructive pulmonary disease. Thorax (1995) 0.88
Sleep, sleep disordered breathing, and nocturnal hypoventilation in children with neuromuscular diseases. Paediatr Respir Rev (2010) 0.86
Respiratory muscle activity during rapid eye movement (REM) sleep in patients with chronic obstructive pulmonary disease. Thorax (1995) 0.84
Central sleep apnoea-a clinical review. J Thorac Dis (2015) 0.80
Circulation time measurement from sleep studies in patients with obstructive sleep apnea. J Clin Sleep Med (2014) 0.77
Are sleep studies necessary in COPD? Lung (1990) 0.76
Sleep and sleep disorders in rare hereditary diseases: a reminder for the pediatrician, pediatric and adult neurologist, general practitioner, and sleep specialist. Front Neurol (2014) 0.75
Central sleep related breathing disorders - diagnostic and therapeutic features. GMS Curr Top Otorhinolaryngol Head Neck Surg (2006) 0.75
Transient hypoxaemia during sleep in chronic bronchitis and emphysema. Lancet (1979) 4.85
The sleep hypopnea syndrome. Am Rev Respir Dis (1988) 3.31
Treatment with continuous positive airway pressure is not effective in patients with sleep apnea but no daytime sleepiness. a randomized, controlled trial. Ann Intern Med (2001) 3.19
Long-term use of CPAP therapy for sleep apnea/hypopnea syndrome. Am J Respir Crit Care Med (1999) 2.98
Randomized placebo-controlled crossover trial of continuous positive airway pressure for mild sleep Apnea/Hypopnea syndrome. Am J Respir Crit Care Med (1999) 2.77
Motivations for sex and risky sexual behavior among adolescents and young adults: a functional perspective. J Pers Soc Psychol (1998) 2.71
Randomized placebo-controlled trial of continuous positive airway pressure on blood pressure in the sleep apnea-hypopnea syndrome. Am J Respir Crit Care Med (2001) 2.68
Effect of continuous positive airway pressure treatment on daytime function in sleep apnoea/hypopnoea syndrome. Lancet (1994) 2.68
The bmi-1 oncoprotein is differentially expressed in non-small cell lung cancer and correlates with INK4A-ARF locus expression. Br J Cancer (2001) 2.67
Self-reported use of CPAP and benefits of CPAP therapy: a patient survey. Chest (1996) 2.58
Effect of CPAP therapy on daytime function in patients with mild sleep apnoea/hypopnoea syndrome. Thorax (1997) 2.47
Evaluation of a portable device for diagnosing the sleep apnoea/hypopnoea syndrome. Eur Respir J (2003) 2.42
Accuracy sensitivity to carboxyhemoglobin, and speed of response of the Hewlett-Packard 47201A ear oximeter. Am Rev Respir Dis (1979) 2.17
Factors impairing daytime performance in patients with sleep apnea/hypopnea syndrome. Arch Intern Med (1992) 2.15
Neck soft tissue and fat distribution: comparison between normal men and women by magnetic resonance imaging. Thorax (1999) 2.12
Can intensive support improve continuous positive airway pressure use in patients with the sleep apnea/hypopnea syndrome? Am J Respir Crit Care Med (1999) 2.02
Sleep apnoea: clinical importance and facilities for investigation and treatment in the UK. Addendum to the 1993 Royal College of Physicians Sleep Apnoea report. J R Coll Physicians Lond (1999) 2.01
The effect of nonvisible sleep fragmentation on daytime function. Am J Respir Crit Care Med (1997) 1.98
Cyclin D1 overexpression in bronchial epithelia of patients with lung cancer is associated with smoking and predicts survival. J Clin Oncol (2003) 1.94
Sleep disturbances and psychiatric disorders associated with posttraumatic stress disorder in the general population. Compr Psychiatry (2001) 1.93
Sleep. 4: Sleepiness, cognitive function, and quality of life in obstructive sleep apnoea/hypopnoea syndrome. Thorax (2004) 1.93
Compliance with CPAP therapy in patients with the sleep apnoea/hypopnoea syndrome. Thorax (1994) 1.85
Uvulopalatopharyngoplasty may compromise nasal CPAP therapy in sleep apnea syndrome. Am J Respir Crit Care Med (1996) 1.84
Randomised placebo controlled trial of daytime function after continuous positive airway pressure (CPAP) therapy for the sleep apnoea/hypopnoea syndrome. Thorax (1998) 1.77
Salmeterol in nocturnal asthma: a double blind, placebo controlled trial of a long acting inhaled beta 2 agonist. BMJ (1990) 1.73
Cognitive function in the sleep apnea/hypopnea syndrome (SAHS). Sleep (2000) 1.66
Irregular breathing and hypoxaemia during sleep in chronic stable asthma. Lancet (1982) 1.65
Hypoxic ventilatory response decreases during sleep in normal men. Am Rev Respir Dis (1982) 1.62
The effect of oxygenation on sleep quality in chronic bronchitis and emphysema. Am Rev Respir Dis (1982) 1.62
Neck and total body fat deposition in nonobese and obese patients with sleep apnea compared with that in control subjects. Am J Respir Crit Care Med (1998) 1.61
Bronchodilatation and the site of airway resistance in severe chronic bronchitis. Thorax (1979) 1.60
Transient hypoxemia during sleep in chronic obstructive pulmonary disease is not a sleep apnea syndrome. Am Rev Respir Dis (1983) 1.58
A common polymorphism in the methylenetetrahydrofolate reductase gene, homocysteine, and ischemic cerebrovascular disease. Stroke (1997) 1.58
Clinical features of the sleep apnoea/hypopnoea syndrome. Q J Med (1989) 1.56
Sleep-disordered breathing after stroke: a randomised controlled trial of continuous positive airway pressure. J Neurol Neurosurg Psychiatry (2006) 1.55
The effect of sleep fragmentation on daytime function. Am J Respir Crit Care Med (1996) 1.55
Pathological assessment of mediastinal lymph nodes in lung cancer: implications for non-invasive mediastinal staging. Thorax (1992) 1.54
Acute respiratory distress syndrome secondary to antisynthetase syndrome is reversible with tacrolimus. Eur Respir J (2008) 1.52
Randomised controlled trial of continuous positive airway pressure and standard oxygen therapy in acute pulmonary oedema; effects on plasma brain natriuretic peptide concentrations. Eur Heart J (2002) 1.52
Under reporting of sleepiness and driving impairment in patients with sleep apnoea/hypopnoea syndrome. J Sleep Res (1997) 1.51
Molecular characterization of planktic cyanobacteria of Anabaena, Aphanizomenon, Microcystis and Planktothrix genera. Int J Syst Evol Microbiol (2001) 1.49
Respiration during sleep in normal man. Thorax (1982) 1.49
Hypercapnic ventilatory response in sleeping adults. Am Rev Respir Dis (1982) 1.48
Evaluation of Biox IIA ear oximeter. Thorax (1985) 1.46
Alcohol and cor pulmonale in chronic bronchitis and emphysema. BMJ (1993) 1.44
Diagnostic values of polysomnography in forensic medicine. J Forensic Sci (2000) 1.42
ABC of sleep disorders. Parasomnias. BMJ (1993) 1.42
Evaluation of bioelectrical impedance analysis for body composition measurements in anorexia nervosa. Clin Phys Physiol Meas (1990) 1.41
Does arousal frequency predict daytime function? Eur Respir J (1998) 1.41
The effect of age, sex, obesity and posture on upper airway size. Eur Respir J (1997) 1.41
Sleepiness-related accidents in sleep apnea patients. Sleep (2000) 1.40
Breathing patterns during sleep in patients with nocturnal asthma. Thorax (1987) 1.39
Neuropsychiatry--the mind embrained? J Psychosom Res (1997) 1.38
Functional assessment of chest wall integrity after methylmethacrylate reconstruction. Ann Thorac Surg (2000) 1.36
Effect of continuous positive airway pressure on sleep architecture in the sleep apnea-hypopnea syndrome: a randomized controlled trial. Am J Respir Crit Care Med (2001) 1.36
Can psychological factors help us to determine adherence to CPAP? A prospective study. Eur Respir J (2004) 1.36
The effect of posture on upper airway dimensions in normal subjects and in patients with the sleep apnea/hypopnea syndrome. Am Rev Respir Dis (1991) 1.35
Effect of sleep deprivation on overnight bronchoconstriction in nocturnal asthma. Thorax (1986) 1.34
Spectral oscillations of RR intervals in sleep apnoea/hypopnoea syndrome patients. Eur Respir J (2003) 1.33
Comparison of nose and face mask CPAP therapy for sleep apnoea. Thorax (1998) 1.29
Family studies in patients with the sleep apnea-hypopnea syndrome. Ann Intern Med (1995) 1.28
The socioeconomic impact of insomnia. An overview. Pharmacoeconomics (1996) 1.27
Partners of patients with sleep apnoea/hypopnoea syndrome: effect of CPAP treatment on sleep quality and quality of life. Thorax (2001) 1.27
Sleep-disordered breathing and upper airway size in pregnancy and post-partum. Eur Respir J (2006) 1.25
Management of obstructive sleep apnoea/hypopnoea syndrome. Lancet (1994) 1.23
Frequency of EEG arousals from nocturnal sleep in normal subjects. Sleep (1995) 1.23
Sexual influence on the control of breathing. J Appl Physiol Respir Environ Exerc Physiol (1983) 1.22
Myosin light chain-2 mutation affects flight, wing beat frequency, and indirect flight muscle contraction kinetics in Drosophila. J Cell Biol (1992) 1.21
Tumour necrosis factor-alpha (-308) gene polymorphism in obstructive sleep apnoea-hypopnoea syndrome. Eur Respir J (2005) 1.21
Twenty four hour heart rate variability: effects of posture, sleep, and time of day in healthy controls and comparison with bedside tests of autonomic function in diabetic patients. Br Heart J (1991) 1.20
Morbidity in nocturnal asthma: sleep quality and daytime cognitive performance. Thorax (1991) 1.18
ABC of sleep disorders. Non-Psychotropic drugs and sleep. BMJ (1993) 1.17
Origin and prognostic value of circulating KRAS mutations in lung cancer patients. Cancer Lett (2007) 1.17
Y(1)-mediated effect of neuropeptide Y in cancer: breast carcinomas as targets. Cancer Res (2001) 1.13
Evaluation of a computerised polysomnography system. Thorax (1993) 1.13
Structure of lifestyle disruptions in chronic disease: a confirmatory factor analysis of the Illness Intrusiveness Ratings Scale. Med Care (2001) 1.12
Snoring, asthma and sleep disturbance in Britain: a community-based survey. Eur Respir J (1993) 1.12
ABC of sleep disorders. Psychotropic drugs and sleep. BMJ (1993) 1.12
Daytime sleepiness, cognitive performance and mood after continuous positive airway pressure for the sleep apnoea/hypopnoea syndrome. Thorax (1993) 1.12
Night-to-night variation of the oxygen desaturation index in sleep apnoea syndrome. Eur Respir J (2004) 1.11
Pulmonary function testing after operative stabilisation of the chest wall for flail chest. Eur J Cardiothorac Surg (2001) 1.11
Sleep deprivation and the control of ventilation. Am Rev Respir Dis (1983) 1.11
Predictors of improvements in daytime function outcomes with CPAP therapy. Am J Respir Crit Care Med (2000) 1.10
Use of home sleep studies for diagnosis of the sleep apnoea/hypopnoea syndrome. Thorax (1997) 1.10
Nocturnal panic--an underrecognized entity. J Psychosom Res (1998) 1.10
Tongue protrusion strength and fatiguability: relationship to apnoea/hypopnoea index and age. J Sleep Res (2000) 1.10
Nocturnal cough in patients with chronic bronchitis and emphysema. Am Rev Respir Dis (1984) 1.09
Effect of an inhaled atropinelike agent on normal airway function. J Appl Physiol Respir Environ Exerc Physiol (1979) 1.09
Hypoxic ventilatory response during sleep in normal premenopausal women. Am Rev Respir Dis (1982) 1.09
ABC of sleep disorders. Sleep disorders in children. BMJ (1993) 1.08
Asthma at night. Clin Chest Med (1985) 1.08
Continuous positive airway pressure improves vascular function in obstructive sleep apnoea/hypopnoea syndrome: a randomised controlled trial. Thorax (2008) 1.08